Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for IP 10 (compound)
Most Correlated Studies
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Most Relevant Literature
- Long-term exposure of chemokine CXCL10 causes bronchiolitis-like inflammation.
- Thiazolidinediones inhibit airway smooth muscle release of the chemokine CXCL10: in vitro comparison…
- β (CCL2) and α (CXCL10) chemokine modulations by cytokines and peroxisome proliferator-activated rec…
- Equine herpesvirus type-1 modulates CCL2, CCL3, CCL5, CXCL9, and CXCL10 chemokine expression.
- Influence of methimazole and radioactive iodine treatment in the serum levels of the chemokine CXCL1…
Most Relevant Clinical Trials
- Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Pati…
- Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS
- IP Peru, Bioavailability of Iron From Potatoes
- Modeling Bronchial Epithelium Modifications Associated With COPD Using iPS
- The Turkish Version of the AOFAS Hallux MTP-IP
